Clinical Trials Directory

Trials / Suspended

SuspendedNCT06095011

Posture Correction in Cubital Tunnel Syndrome

Posture Correction for the Treatment of Cubital Tunnel Syndrome (CuTS)

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Yale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine whether the UpRight Go posture trainer reduces the symptoms of cubital tunnel syndrome in patients who have not had corrective surgery, as determined by improvements in VAS scores for pain, numbness, and weakness.

Detailed description

This is a randomized controlled, non-blinded trial. All patients who are eligible to participate and who consent to participate will be randomized to either receive standard of care treatment alone, or standard of care treatment with the additional intervention of posture training. The nature of the intervention prevents blinding. All patients will be followed for 6 weeks and evaluated for symptom improvement or resolution. All patients aged 18 and older who present to clinic with cubital tunnel syndrome of any severity and who have not previously undergone surgical intervention for this condition will be eligible to participate in this study. All participants must be amenable to conservative management of CuTS, wearing a posture training device daily, completing the accompanying questionnaires throughout the study, and returning for follow-up.

Conditions

Interventions

TypeNameDescription
DEVICEUpRight GoThe UpRight Go posture trainer is a commercially available biofeedback sensor that externally attaches to the wearer via a necklace or silicon adhesive. It vibrates when it senses that the wearer is slouching and connects to a smartphone application which sets daily goals, tracks usage, and provides assistance and support. It complies with International Electrotechnical Commission (IEC) standards.

Timeline

Start date
2023-12-15
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2023-10-23
Last updated
2025-09-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06095011. Inclusion in this directory is not an endorsement.